Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Phase II trial of vincristine infusion in acute leukemia
D V Jackson, A R Chauvenet, R D Callahan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
C M Rocha-Lima, J E Herndon, M E Lee, et al.
Cancer
|
January 1, 1997
Recruiting cancer patients to participate in motivating their relatives to quit smoking. A cancer control study of the Cancer and Leukemia Group B (CALGB 9072)
A Schilling, M R Conaway, P J Wingate, et al.
The American Journal of Medicine
|
June 1, 1988
Amelioration of vincristine neurotoxicity by glutamic acid
D V Jackson, H B Wells, J N Atkins, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study
J B Craig, B L Powell, D V Jackson, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532
M C Perry, D C Ihde, J E Herndon, et al.
American Journal of Clinical Oncology
|
December 1, 1991
High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association
J N Atkins, H B Muss, D Case, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2005
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group
C S Cleeland, R K Portenoy, M Rue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2008
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
J E Rosenberg, S Halabi, B L Sanford, et al.
Seminars in Oncology
|
June 1, 1985
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies
H B Muss, R L Capizzi, J N Atkins, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Phase II trial of vincristine infusion in acute leukemia
D V Jackson, A R Chauvenet, R D Callahan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
C M Rocha-Lima, J E Herndon, M E Lee, et al.
Cancer
|
January 1, 1997
Recruiting cancer patients to participate in motivating their relatives to quit smoking. A cancer control study of the Cancer and Leukemia Group B (CALGB 9072)
A Schilling, M R Conaway, P J Wingate, et al.
The American Journal of Medicine
|
June 1, 1988
Amelioration of vincristine neurotoxicity by glutamic acid
D V Jackson, H B Wells, J N Atkins, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study
J B Craig, B L Powell, D V Jackson, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532
M C Perry, D C Ihde, J E Herndon, et al.
American Journal of Clinical Oncology
|
December 1, 1991
High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association
J N Atkins, H B Muss, D Case, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2005
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group
C S Cleeland, R K Portenoy, M Rue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2008
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
J E Rosenberg, S Halabi, B L Sanford, et al.
Seminars in Oncology
|
June 1, 1985
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies
H B Muss, R L Capizzi, J N Atkins, et al.
Page
of 4